字體：小 中 大 |
|
|
|
| 2014/12/23 07:46:29瀏覽567｜回應1｜推薦2 | |
| 2005年9月5日研究報告得到的結論: [被研究人數: 110,688人 (46,399 男性, 64,289女性), 年齡: 40-79歲] 每日喝咖啡可以降低罹患肝細胞腫瘤 17% 和 50%. 論文指出: 每天喝一杯以上咖啡, 較不喝者減少50%, 每天喝少於一杯者, 較不喝者減少17%. Br J Cancer. 2005 Sep 5;93(5):607-10. Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan. Kurozawa Y1, Ogimoto I, Shibata A, Nose T, Yoshimura T, Suzuki H, Sakata R, Fujita Y, Ichikawa S, Iwai N, Tamakoshi A; JACC Study Group. Author information Abstract We examined the relation between coffee drinking and hepatocellular carcinoma (HCC) mortality in the Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC Study). In total, 110,688 cohort members (46,399 male and 64,289 female subjects) aged 40-79 years were grouped by coffee intake into three categories: one or more cups per day, less than one cup per day and non-coffee drinkers. Cox proportional hazards model by SAS was used to obtain hazard ratio of HCC mortality for each coffee consumption categories. The hazard ratios were adjusted for age, gender, educational status, history of diabetes and liver diseases, smoking habits and alcohol. The hazard ratio of death due to HCC for drinkers of one and more cups of coffee per day, compared with non-coffee drinkers, was 0.50 (95% confidence interval 0.31-0.79), and the ratio for drinkers of less than one cup per day was 0.83 (95% confidence interval 0.54-1.25). Our data confirmed an inverse association between coffee consumption and HCC mortality. |
|
| ( 在地生活｜北美 ) |
